While not a ball-tearer, this and recent announcements demonstrates that BD1 are actually doing the work.
I hold other biotechs where you don't hear nuffink for 12 months, and you really wonder if there is any lab work going on.
These guys are hard at work.
Pretty soon they will be dropping an absolute screamer.
As the CEO said "we have many shots at goal."
Ann: BARD1 Demonstrates Feasibility of SubB2M-Based IHC Test, page-17
-
- There are more pages in this discussion • 66 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
45.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $50.18M | |||
| Open | High | Low | Value | Volume |
| 45.0¢ | 45.0¢ | 45.0¢ | $6.16K | 13.68K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 42909 | 45.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 46.0¢ | 6850 | 1 |
View Market Depth
| Last trade - 13.26pm 11/11/2024 (20 minute delay) ? |
| IIQ (ASX) Chart |